UC Irvine engineers develop a 3D bioelectronic human colon model that mimics real tissue, advancing cancer drug testing.
In a major leap for cancer research and precision medicine, engineers at the University of California, Irvine have developed a three-dimensional human colon model integrated with bioelectronics. The innovation promises a more ethical, accurate, and cost-efficient alternative to animal testing in colorectal cancer research and drug discovery.
The study describes the creation of the “3D in vivo mimicking human colon” model. The miniaturized 5-by-10-millimeter colon replica reproduces key anatomical features, including the organ’s distinctive curvature, layered cellular structure, and cryptlike folds essential to colon function and tumor biology.“The three-dimensional shapes, curves and crypts in our 3D-IVM-HC model are central to maintaining more realistic cell behavior even at a scaled-down size,” said senior author Rahim Esfandyar-pour, UC Irvine assistant professor of electrical engineering and computer science.“And because our model more closely reproduces human colon biology, it could potentially be used to screen drugs or test treatments in a way that better predicts patient responses than animal models or simple cell cultures.”Esfandyar-pour began developing the model after observing critical limitations in preclinical testing methods. He noted that about half of toxicological results from rodent experiments fail to translate accurately to human outcomes.Traditional animal models often miss key aspects of tumor biology and require millions of dollars and years to complete.“Our bioelectronic-integrated 3D-IVM-HC model addresses some of the practical and ethical challenges in animal-based research, offering a human cell-based, animal-free approach with the potential to enable rapid, cost-effective and scalable translational studies,” he said. “By eliminating interspecies variability, the model has the ability to enhance clinical translatability, providing an accelerated and ethically responsible pathway for preclinical research.”Built from human-compatible materialsThe model’s structure is built from a biological scaffold of gelatin methacrylate and alginate, materials chosen to mimic the colon’s soft tissue. Human colon cells line the inner surface, while fibroblasts embedded in the outer layer re-create the mucosal environment that supports colon function.“This intricate architectural arrangement promotes robust cell-to-cell interactions, yielding a fourfold increase in cell density relative to conventional 2D cultures and possibly enhancing physiological relevance and barrier function,” Esfandyar-pour said.When the researchers tested the chemotherapy drug 5-fluorouracil, the 3D model showed stronger drug resistance. Colon cancer cells required about ten times higher doses to reach the same cytotoxic effects seen in standard petri dish cultures. This resistance mirrors real-world clinical outcomes, making the model more predictive for drug testing.Toward personalized, ethical drug discoveryResearchers see the 3D-IVM-HC model as a foundation for personalized medicine. By growing patient-derived cells from tumor biopsies, scientists could build individualized mini-colons to identify which drugs work best for each patient.The model takes roughly two weeks to cultivate and mature, followed by a few days of drug testing – dramatically faster and cheaper than animal studies. This speed allows for higher research throughput while reducing ethical and financial burdens.Esfandyar-pour said the platform could deepen understanding of cancer mechanisms and improve predictive accuracy in drug efficacy assessments. “Hospitals and laboratories could ultimately use such models to run preclinical tests on new therapies in an ethical, timely manner, possibly transforming the drug development pipeline,” he said.The UC Irvine team believes the 3D-IVM-HC model represents a major step toward reliable, humane, and patient-centered cancer research, potentially redefining how the world approaches drug development and precision medicine.The study is published in the journal Advanced Science.
Artificial Colon Bioengineering Cancer Drug Testing Colorectal Cancer Nonanimal Testing Personalized Medicine UC Irvine Research
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Unearthed Artifacts: A Glimpse into Ancient Cultures and Their Views on Life, Death, and the AfterlifeRecent archaeological discoveries reveal ancient cultures' fascinating perspectives on life, death, and the afterlife. From miniature sculptures to party favors, these artifacts offer glimpses into rituals, beliefs, and how different societies grappled with mortality. The findings include a 4,000-year-old basin, an Egyptian statue, a cranial modification case from 12,500 years ago, and a 'banquet ghost' figurine, highlighting the rich tapestry of human experiences across history.
Read more »
Genesis Expands Design Footprint with New North American StudioGenesis, Hyundai's luxury brand, establishes its first North American design studio in Irvine, California, to tailor vehicles to the specific tastes and preferences of the North American market, furthering its global growth strategy and commitment to the region.
Read more »
Ohio Lawmaker Wants to Ban Marriage Between Humans and AI ChatbotsLove should stay between a human and a human, according to one Ohio legislator.
Read more »
Foundations want to curb AI developers’ influence with $500 million aimed at centering human needsThe coalition aims to place human interests at the forefront of the technology’s rapid integration into daily life.
Read more »
Irvine Co. has new plan for apartments, with 12,000 units brewing statewideIrvine Co. is currently building 3,000 units at three sites in Orange County with plans for 9,000 more across California.
Read more »
Nobel chemistry award boosts Irvine startup's air-to-water technology for drought zonesA startup founded by a Nobel laureate is targeting data centers in water-stressed regions as customers for its technology.
Read more »